CORDSTIM-DFUNCT07449975
Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal DFUs
At risk: Primary completion moved at least 4 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
Version history last read from ClinicalTrials.gov on Aug 31, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.
All 1 version: 1 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Primary completion pushed from Jul 2029 to Dec 2029
- Study completion pushed from Sep 2029 to Apr 2030
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
The percentage of target ulcers achieving complete wound closure
Timeframe: 1-12 weeks
Secondary (6)
Time to closure for the target ulcer
Percent area reduction
Adverse events
Change in pain in target ulcer
Determine improvement in Quality of Life - wQOL
Show 1 moreShow less
Determine improvement in Quality of Life - FWS
Arms and interventions
Standard of CareActive comparator
Standard of care will be cleaning, debridement, ulcer moisture balance, and offloading.
Corplex P (and alternate brand names Allacor P and Theracor P)Experimental
Corplex P (and alternate brand names Allacor P and Theracor P) is a dehydrated human umbilical cord-based particulate device.
TheracorExperimental
Theracor is a dehydrated human umbilical cord-based sheet device.
Other: Standard of Care (SOC)
Devices: Corplex P, Theracor